Abstract:ABSTRACT To analyze the characteristics of Mycoplasma pneumoniae as well as macrolide antibiotic resistance through whole-genome sequencing and comparative genomics. Thirteen clinical strains isolated from 2003 to 2019 were selected, 10 of which were resistant to erythromycin (MIC >64 μg/mL), including 8 P1-type I and 2 P1-type II. Three were sensitive (<1 μg/mL) and P1-type II. One resistant strain had an A→G point mutation at position 2064 in region V of the 23S rRNA, the others had it at position 2063, while the three sensitive strains had no mutation here. Genome assembly and comparative genome analysis revealed a high level of genome consistency within the P1 type, and the primary differences in genome sequences concentrated in the region encoding the P1 protein. In P1-type II strains, three specific gene mutations were identified: C162A and A430G in L4 gene and T1112G mutation in the CARDS gene. Clinical information showed seven cases were diagnosed with severe pneumonia, all of which were infected with drug-resistant strains. Notably, BS610A4 and CYM219A1 exhibited a gene multi-copy phenomenon and shared a conserved functional domain with the DUF31 protein family. Clinically, the patients had severe refractory pneumonia, with pleural effusion, necessitating treatment with glucocorticoids and bronchoalveolar lavage. The primary variations between strains occur among different P1-types, while there is a high level of genomic consistency within P1-types. Three mutation loci associated with specific types were identified, and no specific genetic alterations directly related to clinical presentation were observed. IMPORTANCE Mycoplasma pneumoniae is an important pathogen of community-acquired pneumonia, and macrolide resistance brings difficulties to clinical treatment. We analyzed the characteristics of M. pneumoniae as well as macrolide antibiotic resistance through whole-genome sequencing and comparative genomics. The work addressed primary variations between strains that occur among different P1-types, while there is a high level of genomic consistency within P1-types. In P1-type II strains, three specific gene mutations were identified: C162A and A430G in L4 gene and T1112G mutation in the CARDS gene. All the strains isolated from severe pneumonia cases were drug-resistant, two of which exhibited a gene multi-copy phenomenon, sharing a conserved functional domain with the DUF31 protein family. Three mutation loci associated with specific types were identified, and no specific genetic alterations directly related to clinical presentation were observed.

Molecular beacon based real-time PCR p1 gene genotyping, macrolide resistance mutation detection and clinical characteristics analysis of Mycoplasma pneumoniae infections in children

Genotyping of Mycoplasma pneumoniae in nasopharyngeal aspirate from children with pneumonia in Zhejiang Province

Molecular typing of Mycoplasma pneumoniae and its correlation with macrolide resistance in children in Henan of China

Comparative genomic sequencing to characterize Mycoplasma pneumoniae genome, typing, and drug resistance

A single tube modified allele-specific-PCR for rapid detection of erythromycin-resistant Mycoplasma pneumoniae in Beijing

Antimicrobial susceptibility and genotyping of Mycoplasma pneumoniae isolates in Beijing, China, from 2014 to 2016

A method for rapid detection of Mycoplasma pneumoniae and its macrolide resistance mutation

Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis

Detection of Mycoplasma pneumoniae in different respiratory specimens

Comparison of the Molecular Characteristics of Mycoplasma Pneumoniae from Children Across Different Regions of China

Mycoplasma pneumoniae Macrolide Resistance and MLVA Typing in Children in Beijing, China, in 2016: Is It Relevant?

[A multicenter prospective study on early identification of refractory Mycoplasma pneumoniae pneumonia in children].

Diversity in Genotype Distribution of Mycoplasma Pneumoniae Obtained from Children and Adults

Changes in Molecular Characteristics of Mycoplasma Pneumoniae in Clinical Specimens from Children in Beijing Between 2003 and 2015.

Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases

Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates

First report of macrolide-resistant and -susceptible Mycoplasma pneumoniae clinical strains isolated from a single case

Surveillance of Mycoplasma Pneumoniae Infection among Children in Beijing from 2007 to 2012

Multiple-locus variable-number tandem-repeat analysis (MLVA) of macrolide-susceptible and -resistant Mycoplasma pneumoniae in children in Taiwan

Prevalence and Molecular Characteristics of Mycoplasma Pneumoniae in Beijing in the First Half of 2015 and 2016

Molecular Characterizations of Pcr-Positive Mycoplasma Pneumoniae Specimens Collected from Australia and China